These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 32201366)

  • 1. Dissenting degradation: Deubiquitinases in cell cycle and cancer.
    Bonacci T; Emanuele MJ
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cezanne/OTUD7B is a cell cycle-regulated deubiquitinase that antagonizes the degradation of APC/C substrates.
    Bonacci T; Suzuki A; Grant GD; Stanley N; Cook JG; Brown NG; Emanuele MJ
    EMBO J; 2018 Aug; 37(16):. PubMed ID: 29973362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of DUBs Regulation in Signaling and Disease.
    Li Y; Reverter D
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A balance of deubiquitinating enzymes controls cell cycle entry.
    Mapa CE; Arsenault HE; Conti MM; Poti KE; Benanti JA
    Mol Biol Cell; 2018 Nov; 29(23):2821-2834. PubMed ID: 30207830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes.
    Doherty LM; Mills CE; Boswell SA; Liu X; Hoyt CT; Gyori B; Buhrlage SJ; Sorger PK
    Elife; 2022 Jun; 11():. PubMed ID: 35737447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
    Kumar P; Kumar P; Mandal D; Velayutham R
    Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
    Christine A; Park MK; Song SJ; Song MS
    Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation.
    Palazón-Riquelme P; Worboys JD; Green J; Valera A; Martín-Sánchez F; Pellegrini C; Brough D; López-Castejón G
    EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30206189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses.
    Cheng N; Trejo J
    J Biol Chem; 2023 Dec; 299(12):105370. PubMed ID: 37865315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 stability is regulated by diverse deubiquitinating enzymes.
    Kwon SK; Saindane M; Baek KH
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):404-411. PubMed ID: 28801249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Roles of USP18: From Biology to Pathophysiology.
    Kang JA; Jeon YJ
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy.
    Lai KP; Chen J; Tse WKF
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases.
    Estavoyer B; Messmer C; Echbicheb M; Rudd CE; Milot E; Affar EB
    J Biol Chem; 2022 Aug; 298(8):102198. PubMed ID: 35764170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease.
    Rawat R; Starczynowski DT; Ntziachristos P
    Curr Opin Cell Biol; 2019 Jun; 58():85-94. PubMed ID: 30897496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTMs in conversation: activity and function of deubiquitinating enzymes regulated via post-translational modifications.
    Kessler BM; Edelmann MJ
    Cell Biochem Biophys; 2011 Jun; 60(1-2):21-38. PubMed ID: 21480003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.
    Zhou L; Qin B; Yassine DM; Luo M; Liu X; Wang F; Wang Y
    Biochem Pharmacol; 2023 Jul; 213():115624. PubMed ID: 37245535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates.
    Trulsson F; Akimov V; Robu M; van Overbeek N; Berrocal DAP; Shah RG; Cox J; Shah GM; Blagoev B; Vertegaal ACO
    Nat Commun; 2022 May; 13(1):2736. PubMed ID: 35585066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment.
    Carreira LD; Oliveira RI; Moreira VM; Salvador JAR
    Expert Opin Ther Targets; 2023; 27(11):1043-1058. PubMed ID: 37789645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
    Moghadasi SA; Moraes SN; Harris RS
    J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future directions of USP7 interactome in cancer study.
    Park HB; Baek KH
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188992. PubMed ID: 37775071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.